These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33355953)

  • 1. Prevalence and Clinical Impact of SARS-CoV-2 Silent Carriers Among Actively Treated Patients with Cancer During the COVID-19 Pandemic.
    Zambelli A; Chiudinelli L; Fotia V; Negrini G; Bosetti T; Callegaro A; Di Croce A; Caremoli ER; Moro C; Milesi L; Poletti P; Tasca C; Mandalà M; Merelli B; Mosconi S; Arnoldi E; Bettini A; Bonomi L; Messina C; Ghilardi L; Chirco A; Maracino M; Tondini C
    Oncologist; 2021 Apr; 26(4):341-347. PubMed ID: 33355953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of SARS-CoV-2 infection prevalence in 860 cancer patients with a combined screening procedure including triage, molecular nasopharyngeal swabs and rapid serological test. A report from the first epidemic wave.
    Candoni A; Petruzzellis G; Sperotto A; Andreotti V; Giavarra M; Corvaja C; Minisini A; Comuzzi C; Tascini C; Fanin R; Fasola G
    PLoS One; 2022; 17(2):e0262784. PubMed ID: 35108300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era.
    Arpino G; De Angelis C; De Placido P; Pietroluongo E; Formisano L; Bianco R; Fiore G; Montella E; Forestieri V; Lauria R; Cardalesi C; Vozzella EA; Iervolino A; Giuliano M; De Placido S
    ESMO Open; 2020 Sep; 5(5):e000885. PubMed ID: 32958531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.
    Lahner E; Dilaghi E; Prestigiacomo C; Alessio G; Marcellini L; Simmaco M; Santino I; Orsi GB; Anibaldi P; Marcolongo A; Annibale B; Napoli C
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32575505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic.
    Canetti D; Dell'Acqua R; Riccardi N; Della Torre L; Bigoloni A; Muccini C; Bruzzesi E; Ranzenigo M; Chiurlo M; Racca S; Galli C; Castagna A; Tambussi G; Lazzarin A
    New Microbiol; 2020 Oct; 43(4):161-165. PubMed ID: 33135083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) universal screening in gravids during labor and delivery.
    Savirón-Cornudella R; Villalba A; Zapardiel J; Andeyro-Garcia M; Esteban LM; Pérez-López FR
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():400-404. PubMed ID: 33285496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and lombardy: TESTing the impact of the first wave of the pandemic.
    Perico L; Tomasoni S; Peracchi T; Perna A; Pezzotta A; Remuzzi G; Benigni A
    EBioMedicine; 2020 Nov; 61():103069. PubMed ID: 33130396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Performance of Serological (IgM/IgG) and Molecular Testing (RT-PCR) of COVID-19 in Three Private Universities in Cameroon during the Pandemic.
    Kamga Wouambo R; Djuikoué CI; Esemu LF; Kagoue Simeni LA; Tchitchoua MC; Djouela Djoulako PD; Fokam J; Singwe-Ngandeu M; Mpoudi Ngolé E; Apalata T
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rate of SARS-CoV-2 among asymptomatic non-immunised low-risk parturient women between the two waves.
    Al-Hussaini TK; EzzEldin AM; Shaaban OM; Abdel-Aleem MA; Kamal DT; Ibrahim MN
    J Obstet Gynaecol; 2022 Aug; 42(6):1868-1873. PubMed ID: 35484953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potential Transmission of SARS-CoV-2 from Patients with Negative RT-PCR Swab Tests to Others: Two Related Clusters of COVID-19 Outbreak.
    Cao G; Tang S; Yang D; Shi W; Wang X; Wang H; Li C; Wei J; Ma L
    Jpn J Infect Dis; 2020 Nov; 73(6):399-403. PubMed ID: 32475877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.
    Charlton CL; Nguyen LT; Bailey A; Fenton J; Plitt SS; Marohn C; Lau C; Hinshaw D; Lutsiak C; Simmonds K; Kanji JN; Zelyas N; Lee N; Mengel M; Tipples G
    Microbiol Spectr; 2021 Sep; 9(1):e0029121. PubMed ID: 34406813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Clinical Application of a Rapid and Sensitive Loop-Mediated Isothermal Amplification Test for SARS-CoV-2 Infection.
    Hu X; Deng Q; Li J; Chen J; Wang Z; Zhang X; Fang Z; Li H; Zhao Y; Yu P; Li W; Wang X; Li S; Zhang L; Hou T
    mSphere; 2020 Aug; 5(4):. PubMed ID: 32848011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid serological tests for SARS-CoV-2 IgG/IgM - not worth attention?
    Krygier R; Stępień PM; Zarębska-Michaluk D
    Int J Occup Med Environ Health; 2021 May; 34(2):203-209. PubMed ID: 33734216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeatedly negative PCR results in patients with COVID-19 symptoms: Do they have SARS-CoV-2 infection or not?
    Beneš J; Džupová O; Poláková A; Sojková N
    Epidemiol Mikrobiol Imunol; 2021; 70(1):3-9. PubMed ID: 33853332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo.
    Batchi-Bouyou AL; Lobaloba Ingoba L; Ndounga M; Vouvoungui JC; Mfoutou Mapanguy CC; Boumpoutou KR; Ntoumi F
    Int J Infect Dis; 2021 May; 106():3-7. PubMed ID: 33370565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.